Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 10/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | PRKDC | P78527 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.40 |
| ▸ | CDC25C | P30307 | 1/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22738104 | 0.93 | AHR (0.71) | AHRALOX5PRKDCMEN1MAPT | |
| SCHEMBL22760344 | 0.91 | AHR (0.73) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL20821587 | 0.86 | ALOX5 (0.58) | AHRALOX5PRKDCMEN1MAPT | |
| SCHEMBL24097372 | 0.86 | AHR (0.66) | AHRALOX5PRKDCMEN1MAPT | |
| SCHEMBL22129981 | 0.86 | AHR (0.66) | AHRALOX5PRKDCMEN1MAPT | |
| SCHEMBL24090337 | 0.85 | AHR (0.74) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL22078734 | 0.85 | AHR (0.74) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL26195566 | 0.84 | AHR (0.64) | AHRALOX5PRKDCMEN1MAPT | |
| SCHEMBL24097581 | 0.84 | AHR (0.68) | AHRALOX5PRKDCMEN1MAPT | |
| SCHEMBL15497748 | 0.84 | ALOX5 (0.54) | AHRALOX5PRKDCMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844271-B2 | Organic compound, composition, organic optoelectronic device, and display apparatus | SAMSUNG SDI CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844271-B2 | Organic compound, composition, organic optoelectronic device, and display apparatus | SAMSUNG SDI CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-20230371371-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20230371371-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-11-16 | — | — | US | disclosed |
| US-11459316-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device | SAMSUNG SDI CO., LTD. (KR) | 2022-10-04 | — | — | US | disclosed |
| US-20200388765-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS | SAMSUNG SDI CO., LTD. (KR) | 2020-12-10 | — | — | US | disclosed |
| US-20200377489-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377489-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OCIAD1, OCIAD2, OXER1 | AHR 1924/4885ALOX5 395/4885PRKDC 3103/4885 |
| US-20230371371-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OCIAD1, OXER1, OR10J3 | AHR 2046/4885ALOX5 313/4885PRKDC 3429/4885 |
| US-20200388765-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS | OCIAD1, OXER1, OR10J3 | AHR 2625/4885ALOX5 402/4885PRKDC 3169/4885 |
| US-11459316-B2 | Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device | OCIAD1, OCIAD2, OXER1 | AHR 1924/4885ALOX5 395/4885PRKDC 3103/4885 |
| US-11844271-B2 | Organic compound, composition, organic optoelectronic device, and display apparatus | OCIAD1, OXER1, OR10J3 | AHR 2625/4885ALOX5 402/4885PRKDC 3169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.